4 Merger and Acquisitions Stock Stories Ready for a Thursday Appraisal
GlaxoSmithKline plc (NYSE:GSK): Current price $51.49
Knowledgeable sources say that Suntory Beverage & Food of Japan is in advanced negotiations to acquire Glaxo’s Lucozade and Ribena drinks for over $1.6 billion in a deal that would avert an auction of the brands. An agreement might be announced in the next few days, according to one of the sources on Thursday. GlaxoSmithKline, the United Kingdom’s number-one drugmaker, announced plans in April to divest Lucozade and Ribena — which are top sellers in Britain — but do not have worldwide appeal as the firm tries to make its consumer health business more centered.
Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.